Showing results (531-540 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|April 17, 2023
A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coinFederica Cosso, Giandomenico Roviello, Martina Catalano, et al.
Anti-Cancer Drugs|April 17, 2023
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myelomaMuhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, et al.
Anti-Cancer Drugs|July 9, 2020
Calcium channel blockers in pancreatic cancer: increased overall survival in a retrospective cohort studySamuel J Tingle, George R Severs, John A G Moir, et al.
Anti-Cancer Drugs|March 13, 2015
Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expressionQun Hang, Ruochuan Sun, Congqiao Jiang, et al.
Anti-Cancer Drugs|March 13, 2015
Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer NetworkRoberta Sanfilippo, Palma Dileo, Jean-Yves Blay, et al.
Anti-Cancer Drugs|May 4, 2023
Gilteritinib-induced severe immune-related enteritis: a possible case reportPan Luo, Huiying Qiu, Yushan Yang, et al.
Anti-Cancer Drugs|May 25, 2023
Complete response of recurrent perihilar cholangiocarcinoma following sintilimab combined with lenvatinib plus S-1: a case report and review of literatureQin-Qin Liu, Xian-Huan Yu, Qi-Bin Tang, et al.
Anti-Cancer Drugs|May 25, 2023
Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinibAlessandro Di Federico, Andrea De Giglio, Francesca Sperandi, et al.
Anti-Cancer Drugs|July 23, 2020
A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancerHui Li, Yan Liu, Xianhong Liu, et al.
Anti-Cancer Drugs|August 16, 2020
Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinomaFangfeng Liu, Chengfang Zhu, Pengfei Gao, et al.
Pageof 464